Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
Hannah
A
A
Department of Nuclear Medicine and Centre for Positron Emission Tomography, the Ludwig Institute for Cancer Research, Austin & Repatriation Medical Centre, Heidelberg, Victoria, Australia.
Feigen
M
M
Quong
G
G
Akhurst
T
T
Berlangieri
S U
SU
Zimet
A
A
Zalcberg
J
J
McKay
W J
WJ
Scott
A M
AM
D000328:Adult; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008339:Mandibular Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D009062:Mouth Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D019275:Radiopharmaceuticals; D012878:Skin Neoplasms / Q000473:pathology*; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18